Options
3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?
Fecha de emisión
2020
Autor(es)
DOI
10.1016/j.bioorg.2020.103964
Temas
3-Arylcoumarins
3D-QSAR models
Drug design
Molecular docking
Monoamine oxidase B i...
3 ( 2',4' dimethoxyph...
3 ( 3',4' dihydroxyph...
3 ( 3',4' dimethoxyph...
3 ( 3',5' dimethoxyph...
3 ( 5' bromo 2',4' di...
3 arylcoumarin deriva...
8 ethoxy 3 ( 3',4' di...
8 ethoxy 3 ( 3',4',5'...
8 methoxy 3 ( 3 tolyl...
amine oxidase (flavin...
coumarin derivative
dopamine
monoamine oxidase B i...
monoamine oxidase inh...
unclassified drug
animal cell
Article
biological activity
comparative molecular...
comparative molecular...
drug design
drug potency
drug selectivity
drug synthesis
enzyme inhibition
IC50
molecular docking
nonhuman
Parkinson disease
priority journal
probability
protein database
protein degradation
protein function
three dimensional qua...
Archivo(s)